The in vitro susceptibilities of seven representative strains of mutans streptococci to three topically applied chemotherapeutic agents were determined by a modified membrane transfer assay. The MBCs of chlorhexidine and I2-KI ranged from 0.5 to 1.0%, while SnF2 was sublethal at the highest concentration tested (8%) in all but one strain (AHT; mode MBC, 8 .0%). The proposed in vitro assay may be useful for preclinical screening of potential antimicrobial agents prior to use in the oral cavity.
The phenotypically similar group of bacteria collectively known as the mutans streptococci have been implicated as major etiological agents of dental caries. These bacteria, along with other members of the indigenous biota, are capable of forming dense aggregates (dental plaque) on the surface of the teeth. Accordingly, measures to control dentomicrobial infections include attempts to reduce the numbers of this organism by mechanical, chemical, or immunological means (4) . If the appropriate substance can be identified, chemical elimination of mutans streptococci has the potential of being a cost-effective and relatively simple supplement to other means of caries prevention. The ability of an antimicrobial agent to exert bactericidal effects in a relatively short time (e.g., minutes) is a major factor in the selection of potential agents for topical applications in the oral cavity (4) .
Prior to costly clinical testing, in vitro evaluation is an important first step in establishing the potential efficacy of a chemotherapeutic agent. In this regard, it is desirable for in vitro testing to simulate the in vivo situation as closely as possible (2, 4, 10 Fig. 1 ). The bacteriumcovered membranes were then transferred to the diskcontaining plate (bacteria side up) and left in contact with the agent-saturated disks for exactly 5 min. Membranes were then transferred to fresh TS plates containing 0.04% triphenyl tetrazolium chloride dye (TTC; Sigma Chemical Co., St. Louis, Mo.). TTC was added to the medium to denote cell viability (2, 7) . After the plates were incubated for 24 h, the MBC was determined by observing the lowest dilution lethal to the bacteria in the area over which the disk was applied (nonreduced TTC is colorless) (2). The membrane transfer assay was intentionally designed to minimize carry-over; however, the plates were incubated for an additional 48 h to confirm that effects were bactericidal and not inhibitory, since any carry-over of antimicrobial agents would diffuse into the agar and allow reactivation of growth if the bacteria were still viable. All determinations were performed on four separate occasions, and results were recorded as the mode MBC for each strain-agent combination tested (2) .
A TTC-stained membrane illustrating a MBC determination is shown in Fig. 1 . The mode MBCs of the three stock solutions are summarized in Table 2 . These results showed that 0.5 to 1.0% CH and I2-KI were bactericidal for all strains tested. SnF2, however, exhibited sublethal effects at the 8% concentration for all but one strain (AHT; MBC, 8%).
Conventional in vitro methods commonly proposed for testing antibacterial substances (1) may be inappropriate for predicting outcomes against dentomicrobial infections because of the dense masses of bacteria associated with plaque. Conventional in vitro methods are more applicable for serum or tissue infections in which the concentration of bacteria is several orders of magnitude less than those of dentomicrobial infections. The high density of mutans streptococcus cells achieved on the membranes in this investigation more closely resembles the cell densities found in plaque (2) . Another shortcoming of conventional in vitro antimicrobial tests is the duration of exposure to these agents. Conventional disk diffusion assays usually expose antimicrobial agents to bacteria for 16 to 18 h (1). Because plaqueassociated diseases tend to remain localized rather than invasive, topically applied rather than systemically administered antimicrobial therapies may be more effective. Topical substances intended for use in the oral cavity are usually applied for brief periods (e.g., minutes), and therefore the in vitro assay should simulate short exposure times. The proposed membrane transfer assay allows for testing of different concentrations of agents for short periods. Although zones were not scored until 24 h after exposure of the cells to the agents, we observed zones of nonviable cells after 15 min with CH and 12-KI that were comparable to zones after 24 h of incubation. This observation suggests that these agents, when applied at the MBC or above, are immediate in action, and therefore, carry-over of the chemotherapeutic agent is not a confounding factor when results of this assay are interpreted. Moreover, the use of a membrane which restricts carry-over of accumulated agents when the membrane is transferred from contact with the agent-containing disks to a fresh agar plate was done intentionally to minimize carry-over (7) .
Other proposed in vitro susceptibility assays, such as that devised by Tanzer et al. (8) , have advantages similar to those of the membrane transfer assay. In these susceptibility assays, dense aggregates of mutans streptococci are grown on stainless-steel wires and then exposed to various concentrations of antimicrobial agents for different periods of time (8, 10) . In fact, MBCs reported by these investigators for CH and 12-KI are within an order of magnitude of those we report here (9, 10 (11) cleaned the buccal surfaces of molar teeth with a prophylaxis paste containing 9% SnF2. One week later, proportions of S. mutans were markedly reduced. Studies by Keene et al. (6) indicate that a 10% solution of SnF2 may be bactericidal to S. mutans, because treated sites were found to be free of detectable levels of S. mutans several days posttreatment.
In conclusion, the membrane transfer assay may be useful for screening many potential antimicrobial agents for bactericidal effects against cariogenic bacterial strains such as mutans streptococci. We see no reason why this method or a modification would not also be useful for testing antimicrobial agents against local infections by pathogens on other susceptible body surfaces such as skin, genitals, eyes, and nasal tissues. This investigation was supported by Public Health Service grants DE07026, DE00155, and DE02670 from the National Institute of Dental Research.
